Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.

ABSTRACT:

Purpose of review

Acute myeloid leukemia (AML) is a costly disease, and its impact is greater in developing countries (DC). We will review the current concept of what are DC, compare the differences in the epidemiology and economic burden of this disease between developed and DC, and finally, analyze the barriers and possible solutions that DC should implement to achieve better results.

Recent findings

DC is a frequently misunderstood name. The way we use to measure human development is changing, and multidimension metrics better define what are DC. With this in mind, we show the differences in the AML epidemiology and the impact of economic burden in DC. We analyze the barriers to access therapy from a clinician point of view, to show that most DC shared similar challenges

SUBMITTER: Meillon-Garcia LA 

PROVIDER: S-EPMC7538168 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature